Adverum: Assessing The Strong Prospects Of A Gene Therapy Innovator – Seeking Alpha
|
Adverum: Assessing The Strong Prospects Of A Gene Therapy Innovator
Seeking Alpha Gene-based therapy is one of the major waves of medical innovation to power this century. FDA approval of Luxturna signaled a highly favorable regulatory environment for Adverum. In harnessing the power of the AAV delivery vector, Adverum is brewing a … |
